ProCE Banner Activity

Why I Screen for and Treat Hepatitis Delta Virus

Clinical Thought

HDV infection is treatable—but it must be identified to be treated. I consider it our ethical responsibility to increase efforts to identify individuals at risk.

Released: March 29, 2023

Share

Faculty

Heiner Wedemeyer

Heiner Wedemeyer, MD

Professor and Chairman
Department of Gastroenterology, Hepatology and Endocrinology
Hannover Medical School
Hannover, Germany

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This program is supported by an educational grant from

Gilead Sciences, Inc.

Partners

ALF

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Disclosure

Heiner Wedemeyer, MD: consultant/advisor/speaker: Falk, Gilead, GlaxoSmithKline, Janssen, Merck Sharp and Dohme, Roche, Vir Pharmaceuticals; researcher: Biotest.